THORN RUN PARTNERS

Lobbying for OTSUKA AMERICA PHARMACEUTICAL, INC. · Pharmaceutical manufacturer.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · Senate · $50,000.00 income · posted Apr 18, 2026

Lobbying activity 3

Pharmacy

Pharmaceutical reimbursement issues.

Health Issues

Issues related to neurological treatments.

Taxation/Internal Revenue Code

Corporate tax issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.